INTRODUCTION: The aim of this study was to determine the prevalence of TIN and multifocality in men undergoing radical orchiectomy for testicular germ cell tumor (TGCT), and among those with a main tumor size ≤ 2 cm, potentially eligible for testis-sparing surgery.
PATIENTS AND METHODS: Orchiectomy specimens from 126 consecutive patients treated for TGCT tumor between 2003 and 2012 were included. Multifocality was defined as a distinct tumor focus with a diameter ≥ 1 mm separable from the main tumor mass. Uni- and multivariate logistic regression was performed to identify the association between pathological variables and multifocality and to identify variables for predicting clinical stage II to III and pathological stage ≥ pT2.
RESULTS: Of the 126 patients, 103 (82.0%) had clinical stage I cancer at presentation and 23 (18.0%) had clinical stage II to III. The median size of the primary tumor mass was 3.7 cm (range, 0.5-12 cm) in multifocality and 3.0 cm (range, 0.6-8.0 cm) in monofocality, respectively (P < .05). The prevalence of multifocality and TIN was lower in the presence of a smaller main tumor mass (≤ 1 cm) compared with tumors 1.1 to 2.0 cm (P < .05), and increased when the index mass tumor diameter was ≥ 2 cm (P trend < .05). No association was found between tumor histology and multifocality (P = .95) or TIN (P = .54) using the χ2 test.
CONCLUSION: The prevalence of multifocality and TIN was decreased in smaller tumors (≤ 1 cm) and increased when the index mass tumor diameter was ≥ 1.1 cm.
Written by:
Favilla V, Russo GI, Spitaleri F, Urzì D, Madonia M, La Vignera S, Condorelli R, Calogero AE, Cimino S, Morgia G. Are you the author?
Department of Urology, University of Catania, Catania, Italy; Department of Urology, University of Sassari, Sassari, Italy; Department of Medical and Pediatric Sciences, Section of Endocrinology, Andrology, and Internal Medicine, University of Catania, Catania, Italy.
Reference: Clin Genitourin Cancer. 2014 Jun 11. pii: S1558-7673(14)00114-1.
doi: 10.1016/j.clgc.2014.06.009
PubMed Abstract
PMID: 24996692
UroToday.com Testicular Cancer Section
